PMID: 8011304Apr 1, 1994Paper

Identification of coagulase-negative staphylococci and typing of Staphylococcus epidermidis by a 4 h micromethod

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
J O JarløvF Espersen


A new 4 h micromethod (Minibact-S) for identification of coagulase-negative staphylococci (CNS) important in human medicine, Staphylococcus epidermidis, Staphylococcus hominis, Staphylococcus haemolyticus and Staphylococcus saprophyticus, has been investigated. The reproducibility for species identification was 100% and the reproducibility for the single reactions was 95%. When compared to a modified Kloos & Schleifer conventional identification method, discrepant identification was obtained with the Minibact-S in only 8 of 382 clinical and reference strains. The system has been used for typing and biotyping of 201 S. epidermidis strains, and gave a subdivision in 69 different types; 4 related types accounted for 91 (45%) of the isolates, whereas 44 types were represented by only 1 isolate. The discriminatory index was 0.82. In a comparison with other typing methods performed on 81 isolates from 15 patients Minibact-S gave about the same number of types as antibiograms, but in 20% of the patients extra types were obtained with Minibact-S alone compared to antibiogram alone and vice versa. The Minibact-S is of some value in the routine clinical microbiology laboratory as a first screening method for identification of coagulase-n...Continue Reading


Sep 1, 1992·Journal of Medical Microbiology·J O JarløvF Espersen
Jul 1, 1992·The Journal of Infection·M Sheppard, S Jankowski
Dec 1, 1991·The Journal of Hospital Infection·T C BoswellR C Spencer
Jan 1, 1991·Scandinavian Journal of Infectious Diseases·H RingbergA Bredberg
Jul 1, 1991·Journal of Medical Microbiology·J A Lindsay, T V Riley
Apr 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·V T RosdahlP Kjaeldgaard
Jun 1, 1990·Journal of Medical Microbiology·J EtienneJ Fleurette
Nov 1, 1990·Diagnostic Microbiology and Infectious Disease·L A HerwaldtM A Pfaller
Apr 1, 1988·The Journal of Hospital Infection·C Golledge, M Aravena
Jul 1, 1988·The Journal of Hospital Infection·J K Møller
Dec 1, 1986·European Journal of Clinical Microbiology·L PascoliG Santini

❮ Previous
Next ❯


Apr 1, 1997·The Journal of Hospital Infection·J A MartínezM T Jiménez de Anta
May 1, 1995·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·J O JarløvF Espersen
Apr 21, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·J O Jarløv, N Høiby
Feb 15, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·D Lepelletier, H Richet

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.